U
GWPH

UBS’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

UBS’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$386K Sell
4,777
-29,438
-86% -$2.6M ﹤0.01% 4527
2014
Q2 		$3.67M Buy
34,215
+27,736
+428% +$1.93M ﹤0.01% 2253
2014
Q1 		$385K Buy
+6,479
New +$385K ﹤0.01% 4520
2013
Q4 		– Sell
-204
Closed -$4K – 10913
2013
Q3 		$4K Buy
204
+71
+53% +$815 ﹤0.01% 9615
2013
Q2 		$1K Buy
+133
New +$1.18K ﹤0.01% 10066

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

UBS's GWPH Position: Q3 2014 in Review

UBS reduced its GW Pharmaceuticals Plc American Depositary Shares (GWPH) stake by 86% in Q3 2014, selling an estimated $2.6M and leaving 4,777 shares worth $386K. The position accounts for ﹤0.01% of the portfolio, ranked #4527.

UBS first reported a position in GWPH in Q2 2013 and has held it in 5 quarters since. The position peaked at $3.67M in Q2 2014. 87 funds tracked by Wall St. Rank hold GWPH as of Q3 2014.

  • UBS held 4,777 shares of GW Pharmaceuticals Plc American Depositary Shares worth $386K as of Q3 2014.
  • UBS sold 29,438 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2014, an estimated $2.6M.
  • GW Pharmaceuticals Plc American Depositary Shares made up ﹤0.01% of UBS's portfolio in Q3 2014, its #4527 holding.
  • UBS first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2013 and has held it in 5 quarters since.
  • UBS's GW Pharmaceuticals Plc American Depositary Shares position peaked at $3.67M in Q2 2014.
  • 87 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.